Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus

NCT02666807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-01-28

No results posted yet for this study

Summary

This study evaluates the effect of ginger on NF-KB level in Peripheral Blood Mononuclear Cells in type 2 diabetic patients. Half of patients will receive ginger, while the other half will receive placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ginger

Ginger 500 mg capsules (2000 mg per day) by mouth twice daily (BID) for 10 weeks

DIETARY_SUPPLEMENT

placebo

Placebo matching with ginger 0 mg capsules by mouth twice daily (BID) for 10 weeks

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Ahmad Saedisomeolia, Prof.assoc · Tehran University of Medical Sciences

  • Motahare Makhdoomiarzati, Msc student · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-11-30
Completion
2015-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02666807 on ClinicalTrials.gov